Fujita, K
Nakai, Y
Kawashima, A
Ujike, T
Nagahara, A
Nakajima, T
Inoue, T
Lee, C M
Uemura, M
Miyagawa, Y
Kaneda, Y
Nonomura, N
Article History
Received: 7 February 2017
Revised: 1 March 2017
Accepted: 4 March 2017
First Online: 12 May 2017
Competing interests
: Toshihiro Nakajima is the CEO of GenomIdea, Inc. Yasufumi Kaneda is a stock-holder (0.3%) of GenomIdea, Inc. The other authors declare no conflict of interest.